skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Cerebral edema following iodine-131 therapy for thyroid carcinoma metastatic to the brain

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5268755

Brain metastases are rare in well-differentiated thyroid carcinoma but when present they can lead to the patient's death. Iodine-131 therapy for intracerebral thyroid carcinoma metastases causes radiation-induced acute cerebral edema that can lead to CNS complications and even death. We present a case in which a patient with intracerebral /sup 131/I uptake developed seizures, slurred speech, and muscle weakness 12 hr following /sup 131/I therapy. The patient's CT scan, post-therapy, confirmed an intracranial metastasis with a significant amount of surrounding edema. Radiotherapists, when using external beam radiation to treat intracerebral metastases, commonly place these patients on steroids, glycerol, or mannitol prior to instituting therapy, to prevent complications from radiation-induced cerebral edema. This technique could be applied to /sup 131/I therapy of intracranial thyroid carcinoma metastases as well.

Research Organization:
Univ. of Utah School of Medicine, Salt Lake City
OSTI ID:
5268755
Journal Information:
J. Nucl. Med.; (United States), Vol. 5
Country of Publication:
United States
Language:
English

Similar Records

CARCINOMA OF THE THYROID GLAND WITH METASTATIC QUADRIPARESIS TREATMENT WITH RADIOIODINE AND ITS COMPLICATIONS
Journal Article · Mon Jan 01 00:00:00 EST 1962 · Quart. Bull. Northwestern Univ. Med. School · OSTI ID:5268755

Sudden hemorrhage in metastatic thyroid carcinoma of the brain during treatment with /sup 131/I
Journal Article · Thu Apr 01 00:00:00 EST 1976 · J. Nucl. Med.; (United States) · OSTI ID:5268755

The effect of lithium in radioiodine therapy of metastatic well differentiated thyroid carcinoma
Journal Article · Mon May 01 00:00:00 EDT 1995 · Journal of Nuclear Medicine · OSTI ID:5268755